Absolutely, OTP technology is one of our specialties. We support methadone dispensing software and its interfaces with pump hardware, diversion-control and DEA recordkeeping workflows, and the uptime that a morning dosing line demands. For buprenorphine, we implement EPCS with two-factor authentication and identity proofing so prescribers stay compliant with DEA requirements. We also help you take advantage of the SAMHSA rules that made take-home flexibilities permanent and allow telehealth initiation of buprenorphine, along with the DEA telemedicine flexibilities extended through 2026. That includes reliable telehealth infrastructure, secure remote access for medical directors, and monitoring that alerts us before a dosing system failure interrupts care.